haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 21:45 IST
  • 31 Mar 2015 14:29
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Mr. Sanjay Asher, alternate director of the Company, has resigned from the board of directors of the Company with a view to ensure compliance with the ceiling on the number of directorship under the Companies Act, 2013.

    PDF · -
  • 17 Dec 2014 15:55
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the board of directors of the company has appointed Mr. Devang R. Shah as an additional director of the company. He is an independent director on the board.

    PDF · -
  • 31 Oct 2014 11:17
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Shri Bansidhar S. Mehta, a non-executive director of the company, has resigned from the board of directors of the company due to regulatory restrictions.

  • 16 Jan 2014 15:32
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the board of directors of the Company has appointed Ms Krupa R. Gandhi, partner of Bansi S. Mehta & Co., Chartered Accountants, as an additional director of the Company. She is an independent director on the board.

  • 16 Apr 2013 19:04
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Dr. Rajen D. Shah has resigned from the board of directors of the Company w.e.f. April 15, 2013.

  • 19 Apr 2012 14:56
    Management

    Jb Chemicals & Pharmaceuticals Limited has informed the Exchange that the board of directors at its meeting held on April 18, 2012, has appointed Mr. Jashvantrai B. Joshi as a director of the company in casual vacancy. He is an independent director on board of the company. Further, the Company has informed the Exchange that the board of directors at the said meeting, has appointed Mr. Sanjay Asher as an alternate director to Mr. Jashvantrai B. Joshi.

  • 06 Mar 2012 18:51
    Management

    Jb Chemicals & Pharmaceuticals Limited has informed the Exchange that Mr. Rohan Shah has resigned from the board of directors of the company w.e.f. March 05, 2012.

  • 26 Jul 2010 15:32
    Management

    Jb Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors has appointed Dr. Satyanarain Agarwala as an additional director of the Company, on July 24, 2010. Further Dr. Satyanarain Agarwala was earlier appointed as an alternate director to Mr. Vishnu D. Patel. Mr. Vishnu D. Patel ceased to be a director of the Company w.e.f. July 23, 2010, being the date of last annual general meeting, as he did not seek re-election.

  • 21 Oct 2008 17:42
    Management

    Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors has appointed Mr. Mayur Mehta as Compliance Officer. The details of the Compliance Officer are as follows: Mr. Mayur Mehta, Company Secretary - General Manager; Email Id: mayur.mehta@jbcpl.com

  • 04 Jul 2008 12:46
    Management

    Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Mr. Beejal Desai, Vice-President & Company Secretary, has resigned from the services of the Company w.e.f. the close of business hours on June 30, 2008, and Ms. Jenny Dsouza- Asst. Company Secretary of the Company has been appointed as the Compliance Officer of the Company.

  • 11 Apr 2008 09:55
    Management

    Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that "Dr. Rajen D. Shah, Director of the Company ceased to a Whole-time Director (Research & Development) w.e.f. April 1, 2008. However, he will continue on the Board of the Company as a Non Executive Director."

  • 04 Aug 2005 24:00
    Management

    Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Shri Rohit S Shah has resigned from the Directorship of the Company w.e.f. July 29, 2005.

  • 18 May 2005 24:00
    Management

    Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding the following changes in the Directorship of the Company w.e.f. May 12, 2005: 1) Shri C. J. Mody has resigned from the Directorship of the Company. 2) Shri Rajiv Mody has been appointed as Director of the Company to fill-up casual vacancy caused due to the resignation of Shri C. J. Mody. 3) Shri Rohan Singh has been appointed as additional Director of the Company.

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries